Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Union Petrochemical Public Company Limited (UKEM.BK)
Bangkok, TH
Established in 1981 and headquartered in Bangkok, Thailand, Union Petrochemical Public Company Limited primarily imports and distributes chemical products across the country. The company's operations are structured into three principal segments: Commodity Chemicals, Specialty Chemicals, and an 'Other' category. Its business scope further extends to the distribution of plastic pellets, lubricants, and computer equipment, as well as offering computer system services and selling refinery and power plant equipment. Additionally, Union Petrochemical trades in pharmaceutical and medical goods, fragrances, skincare cosmetics, and supplements. The firm also manufactures and markets products derived from coconut food processing and provides short-term credit facilities for the car selling sector.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -8.55% | -6.14% | -9.32% | +59.70% | +84.48% | +84.48% | +118.37% | +2.88% | -6.96% | +76.37% | +167.50% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-17.8% Q1'26: +4.7% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+780.7% ★ Q1'26: +512.9% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+6.9% ★ Q1'26: +2.2% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+3.0% Q1'26: +16.1% (vs Q1'25)
-
ROIC Chemicals: +3.4%+5.3% ★ Q1'26: +31.1% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-1.9% ★ Q1'26: +7.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×6.05× Q1'26: 1.03× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2011 actual |
Dec 2012 actual |
|---|---|---|
| Revenue |
3.26B
est: 3.70B (-11.8%)
|
3.62B
est: 4.10B (-11.8%)
|
| EBITDA |
241.65M
est: 146.50M (+64.9%)
|
208.29M
est: 162.56M (+28.1%)
|
| EBIT |
219.16M
est: 97.49M (+124.8%)
|
200.03M
est: 108.17M (+84.9%)
|
| Net Income |
151.34M
|
110.58M
|
| SGA |
226.28M
est: 344.13M (-34.2%)
|
247.13M
est: 381.84M (-35.3%)
|
| EPS |
0.15
|
0.11
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-28 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-27 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-26 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-25 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-22 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-21 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-15 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-05 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-29 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Somjate Saifon | Member of Executive Board & Executive Director | 390.0K | male |
| Apinya Pleamruk | Accounting & Finance Division Manager and Member of Executive Board | — | female |
| Danai Lulitanond | Assistant Managing Director of Warehouse and Logistics | — | male |
| Ladawan Indaravichai | Head of Internal Audit and Compliance & Corporate Secretary | — | female |
| Peerapol Suwannapasri | MD, Member of Management Board & Director | — | male |
| Perajade Suwannaphasri | Executive Vice President | — | male |
| Suthida Suwannapasri | Deputy MD, Member of Executive Board & Director | — | female |
| Thawinan Borirak | Acting Company Secretary, Internal Audit and Compliance Officer | — | female |
| Ampika Sudjaichun | Assistant General Manager | — | female |
| Virat Suwannapasri | CEO, Executive Director & Chairman of Executive Board | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for UKEM.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
